The Yin and Yang of Regulatory and Commercial Strategy for Execs.
How Early Commercial Assessment Complements and Connects with Your 505(b)(2) Development
Early partnership between commercial and regulatory departments is essential for today’s emerging biotech and pharma company. Decisions made during early phase work ultimately impact the ability to commercialize a product and maximize its value. Even with known compounds a well-supported value proposition needs to be incorporated in to the development plan to deliver the desired launch trajectory.